parsabiv
amgen europe b.v. - etelcalcetide hydrochloride - hyperparathyroidism, secondary - anti-parathyroid agents, calcium homeostasis - parsabiv is indicated for the treatment of secondary hyperparathyroidism (shpt) in adult patients with chronic kidney disease (ckd) on haemodialysis therapy.
parsabiv 2.5mg0.5ml solution for injection vials
amgen ltd - etelcalcetide hydrochloride - solution for injection - 5mg/1ml
parsabiv 5mg1ml solution for injection vials
amgen ltd - etelcalcetide hydrochloride - solution for injection - 5mg/1ml
parsabiv 10mg2ml solution for injection vials
amgen ltd - etelcalcetide hydrochloride - solution for injection - 5mg/1ml
parsabiv
amgen europe b.v. - etelcalcetide as hydrochloride - solution for injection - etelcalcetide as hydrochloride 5 mg / 1 ml - etelcalcetide - parsabiv is indicated for the treatment of secondary hyperparathyroidism (shpt) in adult patients with chronic kidney disease (ckd) on hemodialysis therapy.
parsabiv solution for injection 10 mg2 ml
amgen biotechnology singapore pte ltd - etelcalcetide hydrochloride 11.54 mg eqv etelcalcetide - injection, solution - etelcalcetide hydrochloride 11.54 mg eqv etelcalcetide 10 mg/2 ml
parsabiv solution for injection 2.5 mg0.5 ml
amgen biotechnology singapore pte ltd - etelcalcetide hydrochloride 2.88 mg eqv etelcalcetide - injection, solution - etelcalcetide hydrochloride 2.88 mg eqv etelcalcetide 2.5 mg/0.5 ml
parsabiv solution for injection 5 mgml
amgen biotechnology singapore pte ltd - etelcalcetide hydrochloride 5.77 mg eqv etelcalcetide - injection, solution - etelcalcetide hydrochloride 5.77 mg eqv etelcalcetide 5 mg/ml
parsabiv 5mg solution for injection
amgen biopharmaceuticals malaysia sdn bhd - etelcalcetide hydrochloride -
parsabiv 2.5mg solution for injection
amgen biopharmaceuticals malaysia sdn bhd - etelcalcetide hydrochloride -